A patient with pulmonary metastatic extraskeletal myxoid chondrosarcom
a (EMC), of unknown cause, responded dramatically to 16 months of ther
apy with interferon alfa-2b. This is the first report of a significant
response of a patient with EMC to this novel treatment approach.